Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer

Among patients with endoscopically resected early gastric cancers who were infected with Helicobacter pylori , the incidence of metachronous gastric cancer was 50% lower among those who received active treatment with antibiotics than among controls.

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 378; no. 12; pp. 1085 - 1095
Main Authors Choi, Il Ju, Kook, Myeong-Cherl, Kim, Young-Il, Cho, Soo-Jeong, Lee, Jong Yeul, Kim, Chan Gyoo, Park, Boram, Nam, Byung-Ho
Format Journal Article
LanguageEnglish
Published United States Massachusetts Medical Society 22.03.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Among patients with endoscopically resected early gastric cancers who were infected with Helicobacter pylori , the incidence of metachronous gastric cancer was 50% lower among those who received active treatment with antibiotics than among controls.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa1708423